IFI-M · AS Precision Dual-Axis Series

Specimen SS-F-M2-06842 // MULTI-AXIS · IFI-M

AS Precision Dual-Axis Series I-AG-B

Vitis vinifera

Grape

Tier IAS Precision Dual-Axis Series

Target Trait

1.68×

fold-change

Astringency+Sweet precision dual-axis IFI score

Technical Specifications

SKU

SS-F-M2-06842

Genomic Edits

7

GC Content

46.3%

Construct Length

4,005 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

Polyphenol-astringency axis + TAS1R2/TAS1R3

IFI Score

168

Pathway Edits

  • Polyphenol-astringency axis pathway primary gene cluster overexpression for astringency axis activation
  • TAS1R2/TAS1R3 pathway primary gene cluster overexpression for sweet axis activation
  • Bidirectional promoter system for synchronized A+S dual-axis co-expression
  • Metabolic flux partitioning between IFI-A and IFI-S pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Astringency-Sweet combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for A+S simultaneous accumulation
  • Tissue-specific expression cassette deployment for optimized AS spatial patterning

Key Interventions

Dual-receptor co-activation via synchronized Polyphenol-astringency axis and TAS1R2/TAS1R3 pathway engineeringMetabolic flux partitioning strategy enabling simultaneous astringency and sweet accumulation without competing pathway suppressionPrecision combinatorial regulation for AS multi-axis integrationT-DNA binary vector 2A11 for stable genomic integration of multi-axis construct stack

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I AS dual-axis precision dual platform for food ingredient applications requiring verified combined astringency+sweet sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$349 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities